Synopsys gains on OpenAI partnership and $1B-plus Amazon agreement

Synopsys shares jumped sharply after the chip-design software firm announced multi-year agreements with OpenAI and Amazon Web Services, alongside a fiscal 2027 outlook that comfortably exceeded analyst consensus. The combination of named AI partnerships and elevated forward targets reframed investor expectations for the company's role in increasingly complex AI-driven chip design.

Raised Fiscal Guidance Reshapes Earnings Expectations

Synopsys projected fiscal 2027 revenue of $11.10 billion to $11.20 billion for the year ending October 31, 2027, above the $10.81 billion LSEG analyst average, with non-GAAP EPS guidance of $19.04 to $19.12 against an estimate of $17.81. The company's long-term targets, outlined at its 2026 Investor Day in New York, call for roughly 15% compound annual revenue growth from fiscal 2026 through fiscal 2030 and a non-GAAP operating margin of about 50% by fiscal 2030. Berenberg characterized the investor event as providing "significantly more than the market expected." Among 24 covering analysts, 22 rate the stock "buy" or higher.

Amazon Anchors a $1B-Plus IP Agreement

Amazon Web Services signed a multi-year chip-design intellectual-property and software license worth more than $1 billion, becoming the lead customer for Synopsys's expanded IP business. The agreement links application-optimized IP to Amazon custom silicon through a license-plus-royalty model. It supports the growth strategy, but does not disclose an annual revenue floor or guarantee that the company will reach its growth target.

OpenAI Agreement Extends Synopsys Into AI-Native Chip Design

On the Wednesday before the announcement, Synopsys signed a deal to share revenue with OpenAI to develop an AI model for the chip business. The arrangement positions Synopsys at the intersection of generative AI and semiconductor design tooling, complementing its traditional EDA footprint with a shared revenue framework whose detailed pricing and economics were not disclosed.

Capital Return and Market Validation

Synopsys intends to repurchase about $1 billion of shares over the coming months, subject to market conditions. Rosenblatt lifted its price target to $620 from $575, while StoneX reiterated a Buy with a $570 target, reinforcing the analyst response to the revised outlook. Options flow turned lopsidedly bullish, with call volume running roughly 4.5 times put volume, and three-month implied volatility actually fell 0.89 percentage points to 46.22% even as the stock surged more than 10%.

The next observable milestone is Synopsys's fiscal fourth-quarter results, which may provide updates on the partnerships; the announcements do not establish when their contribution to bookings or revenue will first be disclosed.